Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Optical transillumination spectroscopy: a biomarker of breast tissue density and an intermediate indicator of cancer risk

Not Accessible

Your library or personal account may give you access

Abstract

Optical transillumination spectroscopy provides an alternative to mammographic density as a biomarker of breast density and hence cancer risk, permitting frequent and early use thereby extending cancer risk assessment to younger women.

© 2005 Optical Society of America

PDF Article
More Like This
Optical Transillumination Spectroscopy of Breast Tissue for Cancer Risk Assessment.

Lothar Lüge, Kristina Blyschak, Michelle Simick, and Roberta Jong
5141_278 European Conference on Biomedical Optics (ECBO) 2003

Characterization of breast tissue composition and breast cancer risk assessment using non-invasive Transillumination Breast Spectroscopy (TIBS)

R.A. Weersink, K. M. Blackmore, S. Dick, B.C. Wilson, M. Nielsen, and L. Lilge
ME69 Biomedical Topical Meeting (BIOMED) 2006

Transillumination Breast Spectroscopy (TiBS): Near-infrared optical spectroscopy to monitor bulk tissue changes for breast cancer risk reducing interventions.

Samantha Dick, Kristina Blackmore, Ellen Greenblatt, and Lothar Lilge
BSuE70 Biomedical Optics (BIOMED) 2008

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.